ENvue Medical (FEED) Short term Debt (2014 - 2026)

ENvue Medical's (FEED) quarterly Short term Debt came in at $1.1 million in Q1 2026, down 13.94% year-on-year from $1.3 million in Q1 2025, and little changed on a QoQ basis from $1.1 million in Q4 2025.

ENvue Medical (FEED) Short term Debt (2014 - 2026) Analysis & Trends

ENvue Medical (FEED) has 4 years of Short term Debt data on file, last reported at $1.1 million in Q1 2026.

  • On a quarterly basis, Short term Debt fell 13.94% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 13.94% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, changed N/A from the prior year.
  • Short term Debt for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
  • Over the last five years, Short term Debt for FEED reached as high as $1.3 million in Q1 2025 and fell as low as $1.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.86 Bn 175.56 Bn 6.27 Bn
2 Stryker 128.95 Bn 126.07 Bn 3.81 Bn
3 Medtronic 108.31 Bn 99.09 Bn 6.41 Bn
4 Boston Scientific 68.46 Bn 67.01 Bn 3.61 Bn
5 Edwards Lifesciences 48.25 Bn 44.58 Bn 1.29 Bn
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn
7 GE HealthCare Technologies 28.05 Bn 25.76 Bn 1.98 Bn
8 Smith & Nephew 26.96 Bn 26.38 Bn -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn
10 ENvue Medical 1.20 Mn -1.06 Mn -55,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Mn
Dec 31, 2025 1.08 Mn
Sep 30, 2025 1.04 Mn
Mar 31, 2025 1.26 Mn
Sep 30, 2019 50,000.00
Dec 31, 2014 4.62 Mn